SEOPRO Sets New Benchmark for AI-Driven Pharma Project & Portfolio Management

Goa, 6 February 2026: SEOPRO, the AI-driven Project & Portfolio Management platform developed by Seosaph Infotech, made a decisive impact at the Eminence Business Media’s 9th Annual Pharma Project & Portfolio Management Conference 2026. The platform received strong validation from senior leaders across pharmaceutical R&D, portfolio governance, regulatory affairs and enterprise PMOs.

Positioned as the first AI-enabled project and portfolio management platform built by a pharma leader specifically to address the complexities of regulated pharmaceutical environments, SEOPRO drew attention for its ability to convert fragmented project data into structured, decision-ready intelligence.

During live demonstrations and strategic discussions, industry leaders acknowledged SEOPRO’s capability to make portfolio risk, execution bottlenecks, and decision delays visible early, before they escalate into costly program disruptions.

Industry Recognition

Mr. John Robert, Global Project & Portfolio Leader and Founder, Moonshot Systems, remarked: “SEOPRO is ahead of its time. What stands out is not just the technology, but the clarity of thought behind it. The platform reflects a deep understanding of the real-world complexities of pharma project and portfolio management, and I am keen to explore it further.”

He further commended, “Mr. Ashwini Shrivastava, Product Lead, SEOPRO brings a panoramic understanding of the pharma industry. His hands-on experience across diverse pharma environments is clearly visible in the way SEOPRO addresses practical, on-ground pain points with precision and relevance.”

Strong Validation from the Pharma Fraternity

Across in-depth interactions, delegates from leading pharmaceutical organizations requested personalized follow-up demonstrations, underscoring the platform’s relevance to enterprise-scale portfolio challenges.

Ms. Harshita Shah from Zydus Lifesciences noted: “In pharma project management, complexity is a given - multiple teams, tight timelines, and constant dependencies. What matters most is clarity and trust. What I really appreciate about SEOPRO is that it doesn’t try to replace human judgment but give it a boost. It gives you the right visibility, the right signals, and the right insights - and lets the project manager stay in control.”

She specifically highlighted the platform’s ability to quantify risk with measurable accuracy, a capability often missing in traditional portfolio tools.

Delegates further acknowledged SEOPRO’s differentiated approach to:

• Early risk identification across portfolios, before delays surface
  
  

• Evidence-based portfolio reviews replacing subjective status reporting
  
  

• Traceable, regulator-ready documentation embedded into execution workflows
  
  

• Reduced dependency on repetitive review meetings through real-time intelligence
  

Built for the Reality of Pharma Complexity

Unlike generic SaaS platforms retrofitted for healthcare, SEOPRO has been designed from the ground up by professionals with deep exposure to pharma R&D, regulatory governance, and enterprise-scale program execution.

In highly regulated environments where delays are costly, data integrity is critical, and accountability is non-negotiable, SEOPRO combines AI-driven risk intelligence with human-led decision control.

Reflecting on the response at EBMPPPM 2026, Mr. Ashwini Shrivastava, Product Lead, SEOPRO, stated: “The response has been overwhelming. Being recognized by industry leaders validates our belief that pharma portfolio management requires a fundamentally different, more intelligent approach—one that strengthens decision-making rather than automating it blindly.”

Looking Ahead

SEOPRO’s participation at EBMPPPM 2026 marks a significant milestone in its growing engagement with global pharma organizations seeking smarter, faster, and more defensible portfolio decisions.

Looking at the overwhelming response at the event, Mr. Nagarajan Selvaraj, CEO, Seosaph Infotech commented: “Pharma project and portfolio management cannot rely on fragmented tools and retrospective reporting anymore. The industry needs predictive visibility, accountable decision intelligence and platforms built specifically for regulated environments. SEOPRO was created with that belief. It is not just an automation tool - it is a governance engine designed to strengthen human judgment with evidence. The response at EBMPPPM 2026 reinforces that pharma leaders are ready to move from reactive execution to intelligent portfolio control.”

As one delegate summarized during the event: “SEOPRO doesn’t replace judgment. It strengthens it - with evidence.”

With increasing emphasis on predictive governance, responsible AI, and data-driven portfolio control, SEOPRO is poised to redefine how pharmaceutical enterprises manage complexity in the years ahead.